Status:

UNKNOWN

Phase 1 Study of HBN-1

Lead Sponsor:

Hibernaid, Inc

Conditions:

Cardiac Arrest

Eligibility:

All Genders

40-80 years

Phase:

PHASE1

Brief Summary

Phase 1 First-in Human randomized, open-label, active control standard of care study of the safety of HBN-1 administered as pharmacologically induced hypothermia as an adjunct to standard of care targ...

Detailed Description

Phase 1 First-in Human randomized, open-label, active control standard of care study of the safety of HBN-1 administered as pharmacologically induced hypothermia as an adjunct to standard of care targ...

Eligibility Criteria

Inclusion

  • Age 40 to 80 years, inclusive
  • Documented diagnosis of OHCA with ventricular tachycardia/fibrillation, asystole or pulseless electrical activity
  • Return of spontaneous circulation within 50 minutes of the event
  • FOUR Motor Score \<4
  • Maximum estimated weight not to exceed 100 kg

Exclusion

  • Return of spontaneous circulation \>8 hours
  • Known history of prior cardiac arrest, alcohol, or substance abuse or dependence
  • Presumed etiology of cardiac arrest is trauma, hemorrhage, or sepsis
  • Comfort measures only or anticipated withdrawal of life-support within 24 hours
  • Is within a protected population group (eg, pregnant or breastfeeding or incarcerated persons)
  • Has history or evidence of significant hepatic dysfunction (Sequential Organ Failure Assessment Hepatic score \>2)
  • Any other condition, that in the opinion of the investigator, would preclude the subject from being a suitable candidate, e.g. end-stage chronic illness with no reasonable expectation of survival to hospital discharge
  • Is able to obey to verbal commands
  • Is receiving IV vasopressin or lidocaine hydrochloride

Key Trial Info

Start Date :

October 30 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2020

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT04094857

Start Date

October 30 2019

End Date

December 31 2020

Last Update

October 7 2019

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Maine Medical Center

Portland, Maine, United States, 04103

2

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15261